LOINC
Version 2.73

21386-8Methamphetamine [Presence] in Urine by SAMHSA confirm methodActive

Term Description

The LOINC SAMHSA confirm and SAMHSA screen methods are used to model drug toxicology terms where the testing methodologies follow the HHS, SAMHSA drug testing guidelines.
Source: Regenstrief LOINC, SAMHSA: Drug-testing

Part Description

LP16194-0   Methamphetamine
Methamphetamine (MA) is a drug of abuse also referred to as meth, crystal and speed. It is a central nervous system stimulant that can be injected, smoked, snorted or ingested. Short-term MA abuse causes an increase of energy, sense of well-being and decreased appetite that lasts 6-8 hours.[PMID:19042205] MA use can lead to stroke, cardiac arrhythmia, stomach cramps, shaking, anxiety, insomnia, paranoia, hallucinations, and structural changes to the brain. Pregnant women who use MA can cause growth retardation, premature birth, and developmental disorders in neonates and long lasting intellectual deficits to the children as they grow. [PMID:10908000] Users addicted to MA experience withdrawal symptoms that include dysphoria, fatigue, insomnia and an increased appetite. In chronic MA users positron emission tomography has proven a decrease in dopamine D2 receptors which is associated with mental deterioration that can be reversed to some extent after abstaining from MA.[PMID:19042205] Source: Regenstrief LOINC

Fully-Specified Name

Component
Methamphetamine
Property
PrThr
Time
Pt
System
Urine
Scale
Ord
Method
SAMHSA confirm

Additional Names

Short Name
Methamphet Ur Ql SAMHSA Cfm
Display Name
Methamphetamine SAMHSA confirm method Ql (U)
Consumer Name Alpha
Methamphetamine, Urine

Basic Attributes

Class
DRUG/TOX
Type
Laboratory
First Released
Version 1.0m
Last Updated
Version 2.56
Change Reason
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
Order vs. Observation
Both

Member of these Groups

LG37593-7 Methamphetamine|ANYProp|ANYTm|ANYSys|ANYMeth
LG6973-4 Methamphetamine|PrThr|Pt|ANYUrine

Language Variants Get Info

zh-CNChinese (China)
甲基苯丙胺:存在情况或阈值:时间点:尿液:序数型:SAMHSA 毒理学确认试验
nl-NLDutch (Netherlands)
methamfetamine:aanwezigheid:moment:urine:ordinaal:SAMHSA-bevestiging
fr-FRFrench (France)
Méthamphétamine:Présence/Seuil:Ponctuel:Urine:Qualitatif:Confirmation par SAMHSA
it-ITItalian (Italy)
Metanfetamina:PrThr:Pt:Urine:Ord:SAMHSA, conferma
ko-KRKorean (Korea, Republic of)
메타암페타민:임의농도:검사시점:뇨:순위척도:SAMHSA 확인
pt-BRPortuguese (Brazil)
Metanfetamina:ACnc:Pt:Urina:Ord:Confirmatório drogas de Acuso
es-ARSpanish (Argentina)
confirmado por la Administración de Abuso de Sustancias y Servicios de Salud Mental (SAMHSA):concentración arbitraria:punto en el tiempo:orina:ordinal:SAMHSA CONFIRM
es-MXSpanish (Mexico)
Metanfetamina:Presencia o umbral:Punto temporal:Orina:Ordinal:SAMHSA confirma
es-ESSpanish (Spain)
Metanfetamina:PrThr:Punto temporal:Orina:Ord:Confirmatorio SAMHSA (administración de salud mental y abuso de sustancias)
tr-TRTurkish (Turkey)
Metamfetamin:MevcEşik:Zmlı:İdrar:Srl:SAMHSA doğrulama

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=21386-8